|
 |
EmtrivaThis page contains recent news articles, when available, and an overview of Emtriva but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Emtriva (when available) Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Emtricitabine is phosphorylated to active metabolites that compete for incorporation into viral DNA. They inhibit the HIV reverse transcriptase enzyme competitively and act as a chain terminator of DNA synthesis. The lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated. For the treatment of HIV-1 infection in adults. Mechanism Of Action: Emtricitabine, a synthetic nucleoside analogue of cytidine, is phosphorylated by cellular enzymes to form emtricitabine 5'-triphosphate. Emtricitabine substrate deoxycytidine 5'-triphosphate and by incorporating into nascent viral DNA, which results in chain termination. Emtricitabine 5'-triphosphate is a weak inhibitor of mammalian DNA polymerases alpha, beta, and epsilon and of mitochondrial DNA polymerase gamma. Emtricitabine inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA. News Articles on Emtricitabine Study Identifies Viread And Emtriva As The Preferred Initial Treatment For HIV ... - Dec 10, 2009 A recent study finds Viread (tenofovir) and Emtriva (emtricitabine) are more effective nucleoside reverse transcriptase inhibitors (NRTIs) than Ziagen ... The AIDS Beacon (blog) Gilead shares fall despite surge in 3Q profit - Oct 21, 2009 It is a three-in-one, daily treatment for HIV that contains Gilead ( GILD - news - people )'s Viread and Emtriva, along with Bristol-Myers Squibb Co. ... Forbes Epzicom Associated With More Side Effects In HIV/AIDS Patients Than Truvada - Nov 9, 2009 Truvada is a combination therapy that includes the drugs Emtriva (emtricitabine) and Viread (tenofovir). Alternatively, Epzicom is a combination therapy ... The AIDS Beacon (blog) Generic Name: Tenofovir, emtricitabine - Nov 11, 2009 Do not take Truvada if you are already taking Atripla, Combivir (lamivudine/zidovudine), Emtriva, Epivir or Epivir-HBV (lamivudine), Epzicom (abacavir ... Pattaya Daily News SanDisk Announces Third Quarter 2009 Financial Results - Oct 20, 2009 International 4010 5036 15661 13573 67928 91217 207716 264604 Emtriva - US 3865 4001 11211 11945 Emtriva - Europe 1863 2762 6369 7437 Emtriva - Other ... Reuters BUSINESS WIRE: Gilead Sciences gibt Rekord-Finanzergebnis für das dritte ... - Oct 23, 2009 4.010 5.036 15.661 13.573 international 67.928 91.217 207.716 264.604 Emtriva – USA 3.865 4.001 11.211 11.945 Emtriva – Europa 1.863 2.762 6.369 7.437 ... Vereinigte Wirtschaftsdienste GileadSciencesgibtRekord-Finanzergebnis für das dritteQuartal2009bekannt - Oct 23, 2009 Weitere Antiviralprodukte Die Umsätze mit anderen Antiviralprodukten wie Hepsera® (Adefovir Dipivoxil) und Emtriva® (Emtricitabin) lagen im dritten Quartal ... Reuters GileadSciencesannonce des résultats financiers record pour le troisième ... - Oct 23, 2009 Autres produits antiviraux Les ventes des autres produits antiviraux, qui comprennent l`Hepsera® (adéfovir dipivoxil) et l`Emtriva® (emtricitabine) se sont ... Reuters GILEAD SCIENCES : annonce des résultats financiers record pour le troisième ... - Oct 23, 2009 Les ventes des autres produits antiviraux, qui comprennent l'Hepsera ® (adéfovir dipivoxil) et l'Emtriva ® (emtricitabine) se sont élevées à 74,7 millions ... Zonebourse.com New HIV Regimen Outperforms Gold Standard - Jan 18, 2006 The Viread/Emtriva/Sustiva combination did a better job of reducing viral load and ... The study was designed to show that the Viread/Emtriva/Sustiva ... CNN HIV/AIDS Patients Get 1st Once-Daily Pill - Jul 12, 2006 Atripla combines Viread (tenofovir), Emtriva (emtricitabine) and Sustiva (efavirenz). Viread and Emtriva, both made by Gilead of Foster City, Calif., ... FOXNews Deal on HIV Drug - Jul 19, 2005 Emtriva was first approved by United States regulators in 2003 and is a component of Gilead's Truvada, a pill that combines Emtriva with the HIV drug Viread. New York Times BW50: Gilead's Big Growth Spurt - Apr 25, 2005 In less than two years, Viread, Hepsera, and a second HIV drug, Emtriva, ... While Emtriva is not the commercial success Viread is, it's a crucial ... BusinessWeek Gilead Sciences posts net loss, sales jump - Oct 18, 2006 Third-quarter sales of Viread fell 10% to $170.6, while Emtriva sales fell 21% to $9.3 million. Wall Street had been forecasting Viread sales of $160 ... MarketWatch Gilead HIV Drug Gets Boost From US - Nov 3, 2008 The DHHS named Gilead's Truvada, a combination of the company's HIV treatments Emtriva and Viread, the lone preferred regimen for previously untreated HIV ... TheStreet.com - TheStreet.com (subscription) US reviewing safety of Glaxo, Bristol AIDS drugs - Mar 27, 2008 ...and noted that researchers had not evaluated heart-attack risk when patients were taking two other NRTIs, Gilead Sciences Inc's Viread and Emtriva. ... Reuters Gilead Beats Targets | Robert Steyer News | Print Financial &... - Apr 19, 2005 Truvada combines Emtriva and Viread in a single tablet. Sales of Hepsera, a drug for people with chronic hepatitis B virus, jumped to $42.7 million from ... TheStreet.com - TheStreet.com (subscription) Gilead says Teva files to sell generic of HIV drug - Nov 14, 2008 Truvada is a combination of Gilead's drugs Viread, known generically as tenofovir, and Emtriva, or emtricitabine. Gilead said Teva has claimed that two of ... Reuters … Gilead's Study 934 Comparing Viread(R) and Emtriva(R) to Combivir(R... - Dec 15, 2006 ..."Sustiva, Emtriva and Viread were administered as individual agents in this ... Viread and Emtriva are available as once-daily Truvada® (emtricitabine and ... RedOrbit Atripla Makers Seek European Approval - Oct 9, 2006 The two drugs, Emtriva and Viread, are also prescribed as a once-daily combined tablet known as Truvada. Efavirenz is sold in a number of countries by Merck ... TheStreet.com - TheStreet.com (subscription) Gilead Shares Face Limited Upside - Nov 15, 2005 Gilead expects to file for approval of new triple combination formula featuring its Truvada (Viread/Emtriva) and Bristol-Myers Squibb's (nyse: BMY - news ... Forbes Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine … - Oct 17, 2007 Through 48 weeks, 84 percent of patients in the Viread/Emtriva/SUSTIVA group ... Emtriva, Viread, Truvada and ATRIPLA are not approved for the treatment of ... Free with registration - PR Newswire - AccessMyLibrary.com Gilead Sciences counts on Indian pharma companies - May 14, 2007 The agreements entered into since last September cover two drugs, Emtriva (emtricitabine) and Viread (tenofovir disoproxil fumarate), and allows the Indian ... Hindu Business Line Gilead aims to speed AIDS drugs to poor: Effort is response to... - Aug 12, 2006 Truvada combines Viread and Emtriva in one pill. Emtriva was developed by Triangle Pharmaceuticals, a Durham drug development company Gilead bought in 2003. ... Free with registration - News & Observer - AccessMyLibrary.com New HIV listings added to Pharmaceutical Schedule - Apr 1, 2007 Viread as well as Emtriva are for use in combination with other HIV ... Emtriva is a capsule and dosed as one tablet, taken once daily with or without food. ... scoop.co.nz Gilead Set For Further Upside On Strong HIV Franchise - Apr 19, 2006 In addition, the RBC analyst believes Gilead's Emtriva will continue to dominate the market for NRTIs, or nucleoside reverse transcriptase inhibitors. ... Forbes US university sells rights to Aids drug it developed for $525m. - Jul 21, 2005 Emtriva is one of the main components of many of the most commonly used drug combinations that help prolong the life of people infected with the HIV virus. ... Pay-Per-View - Irish Times - Factiva, from Dow Jones HIV drugs to be subsidised - Mar 16, 2007 The medicines, Tenofovir (Viread) and Emtricitabine (Emtriva), will be subsidised from April 1. Pharmac medical director Peter Moodie said the investment ... New Zealand Herald Gilead gets subpoena related to HIV drugs' marketing, education. - Dec 8, 2006 Truvada is a combination of Viread and Emtriva, also known respectively as tenofovir and emtricitabine. "Gilead intends to comply with the US attorney's ... Free with registration - San Jose Mercury News - AccessMyLibrary.com Netherlands Corporate News - Gilead komt met update over ontwikkeling... - Sep 8, 2005 Safety and efficacy studies using Truvada tablets or using Emtriva and ... Emtriva and Viread have each been studied as part of multi-drug regimens and have ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Researchers find better HIV medication - Jan 19, 2006 As an initial treatment, the once-daily combination of antiretroviral tenofovir DF (Viread), emtricitabine (Emtriva), and efavirenz (Sustiva), works better ... æ–°å?Žç½‘ Article: CDC: AIDS drugs hold promise for prevention - Oakland... - Mar 1, 2007 NRTI Emtriva receives FDA approval The Food and Drug Administration has ... 2003 Data from Study 301 and Additional Emtriva Abstracts Presented at 2nd ... Pay-Per-View - Oakland Tribune - HighBeam Research Truvada, Viread and Emtriva Co-Pay Assistance Program Now Available - Dec 22, 2008 Gilead Sciences has launched a Truvada co-payment assistance program to help eligible people living with HIV reduce their out-of-pocket medication expenses. ... AIDSmeds.com HIV/AIDS Treatment News New AIDS pill combines three medicines. - May 23, 2006 The Sustiva-Viread-Emtriva combination -- currently taken once a day in either two or three pills -- accounts for nearly 20 percent of the market for newly ... Free with registration - San Jose Mercury News - AccessMyLibrary.com … Data From Study 934 Comparing Viread and Emtriva to Combivir Both... - Feb 3, 2005 Participants in one arm of the study receive Viread 300 mg, Emtriva 200 mg ... Similarly, 80 percent of patients in the Viread/Emtriva arm compared to 71 ... $4.95 - Business Wire - ECNext Once-a-day HIV drug cocktail — in one pill — wins FDA approval - Jul 16, 2006 The drugs are Bristol-Myers Squib's Sustiva and Gilead Pharmaceutical's Truvada, a combo of Viread and Emtriva. Taking the trio as a single pill makes it ... USA Today European CHMP Issues Positive Opinion For ATRIPLA(R) (efavirenz 600 … - Oct 19, 2007 Emtriva, Viread, Truvada and ATRIPLA are not approved for the treatment of chronic ... In some of these patients treated with Emtriva, the exacerbations of ... Medical News Today - Medical News Today (press release) Investor Group acquires Emory-Emtriva Brand Rights from Emory … - Jul 22, 2005 US - An investor group, comprised of Gilead Sciences Inc and Royalty Pharma, acquired the brand rights of Emtriva, from Emory University, ... Pay-Per-View - deals - Alacra Store Bristol-Myers Squibb And Gilead Announce Data Supporting … - Jan 9, 2006 Safety and efficacy studies using Truvada tablets or using Emtriva and ... Emtriva and Viread have each been studied as part of multi-drug regimens and have ... webwire.com IAC: Unboosted Atazanavir HIV Regimen Found Inferior - Aug 8, 2008 The combination tested was didanosine (Videx), emtricitabine (Emtriva), and atazanavir (Reyataz), all taken once a day, according to Thomas Campbell, MD, ... MedPage Today Gilead's Debt Sale Seen Fueling Potential Deals - Apr 27, 2006 The triple combination HIV treatment, which consists of Viread and Emtriva from Gilead, along with Sustiva from Bristol-Myers Squibb (nyse: BMY - news ... Forbes … /AIDS Therapy; Data released from study comparing Viread and Emtriva... - Mar 14, 2005 Participants in 1 arm of the study receive Viread 300 mg, Emtriva 200 mg, ... Truvada, Viread, and Emtriva work by blocking reverse transcriptase, ... Pay-Per-View - Pain & Central Nervous System Week - Factiva, from Dow Jones Netherlands Corporate News - Gilead meldt gegevens overstap van … - Oct 29, 2007 Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued Viread(R) (tenofovir disoproxil fumarate) or Emtriva(R) ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Starting or Switching: Truvada Outpaces Combivir in Studies - Jul 26, 2007 Patients in the Viread/Emtriva group had significantly more limb fat (7.9 kg) at week 144 than patients in the Combivir group (5.4 kg). ... AIDSmeds.com HIV/AIDS Treatment News … from Gilead's Study 934 Comparing Viread(R) and Emtriva(R) to... - Aug 14, 2006 Viread, Emtriva and Sustiva are available in the United States as the ... Participants in one arm of the study received Viread 300 mg, Emtriva 200 mg and ... Free with registration - Business Wire - AccessMyLibrary.com Gilead initiates HIV integrase inhibitor trial - Jun 22, 2005 Its other HIV treatment, Emtriva (emtricitabine) is indicated in combination ... In July 2003, Emtriva was cleared for marketing in the United States by the ... DrugResearcher.com European Commission Approves ATRIPLA(R), the First Once-Daily … - Dec 17, 2007 Emtricitabine and tenofovir disoproxil fumarate are commercialized by Gilead Sciences, Inc. (Nasdaq: GILD) under the tradenames Emtriva(R) and Viread(R), ... Lifescience-online … /AIDS Therapy; Data released from study comparing Viread and Emtriva... - Mar 18, 2005 Participants in 1 arm of the study receive Viread 300 mg, Emtriva 200 mg, ... Truvada, Viread, and Emtriva work by blocking reverse transcriptase, ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones California and the West; IN BRIEF / BIOTECHNOLOGY; Gilead Says HIV … - Jan 10, 2006 Researchers showed that a single pill combining Gilead's Viread and Emtriva medicines and Bristol-Myers' Sustiva was equivalent to taking the three drugs ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Unprecedented work key to new HIV pill / Two drug companies … - Jul 20, 2006 Truvada (the Viread and Emtriva combination) runs about $850 a month for 30 ... Gilead Sciences Inc. makes Viread and Emtriva, which is also sold as a ... Pay-Per-View - Richmond Times - Dispatch - ProQuest Archiver A Potential HIV Prophylactic? - Feb 6, 2006 The latter is available on its own under the brand name Emtriva, a product also made by Gilead . Truvada was approved in August 2004 in the United States ... Red Herring 'Pill to prevent AIDS shows promise' - Mar 29, 2006 The drugs are tenofovir (Viread) and emtricitabine, or FTC (Emtriva), sold in combination as Truvada by Gilead Sciences Inc, a California company best known ... Times of India Gilead Sciences at NASDAQ 16th Investor Program Conference - Part 2. - Dec 8, 2005 That payment will be amortized over the lifetime of the Emtriva patent, ... Actually for Truvada, Viread, and Emtriva. UNIDENTIFIED AUDIENCE MEMBER: I ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Metastatix Launches Clinical Trial for Cancer Drug - Dec 5, 2007 Liotta discovered three drugs that are now commercial, including Gilead's Emtriva, which part of the world's top selling HIV cocktail, Truvada. Local Tech Wire Mmegi Online ::> news we need to know - Jan 24, 2006 ...the researchers showed that after one year of treatment, a regimen of antiretroviral pills, called tenofovir DF (Viread) and emtricitabine (Emtriva), ... Mmegi Online FDA Safety Labeling Changes: Emtriva, FazaClo, Climara/Climara Pro - Sep 14, 2005 Sept. 14, 2005 — The US Food and Drug Administration (FDA) approved safety labeling revisions in June to advise that discontinuation of emtricitabine ... Medscape Pill against HIV infection soon: Scientists : HindustanTimes.com - Mar 25, 2007 The drugs are tenofovir (Viread) and emtricitabine, or FTC (Emtriva), sold in combination as Truvada by Gilead Sciences Inc, a California company best known ... HT Tabloid Article: Sustiva-Viread-Emtriva combo for HIV.(Human immunodeficiency... - Feb 15, 2006 Sustiva-Viread-Emtriva combo for HIV.(Human immunodeficiency virus)(Brief Article) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research Sustiva-Viread-Emtriva combo for HIV.(Human immunodeficiency virus)( … - Feb 15, 2006 Combination therapy with Sustiva, Viread, and Emtriva was superior to combined Sustiva and Combivir for treating HIV in treatment-naive patients enrolled in ... Free with registration - Internal Medicine News - AccessMyLibrary.com DRUG FACTS - May 12, 2006 Similar studies are planned for a combination drug, Truvada, that contains Viread and Gilead's Emtriva. Both Viread and Emtriva block the AIDS virus from ... Pay-Per-View - San Jose Mercury News - Factiva, from Dow Jones Gilead Sciences at SG Cowen & Co. 25th Annual Health Care … - Mar 15, 2005 Truvada, Viread, and Emtriva make up our HIV franchise. ... Viread, Emtriva -- or Truvada -- and Systeva are going to be combined into a single pill. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Gilead HIV Drug Combo Beats GSK Rival in Phase III Trial - Jan 20, 2006 Similarly, 80% of patients in the Viread/Emtriva arm compared to 70% of patients in the ... Viread and Emtriva are often prescribed together as a fixed-dose ... RedOrbit Bristol-Myers Squibb, Gilead Sciences And Merck & Co. Submit Marketing... - Oct 10, 2006 Important Safety Information About ATRIPLA, Truvada, Viread and Emtriva Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, ... Medical News Today - Medical News Today (press release) Netherlands Corporate News - Bristol-Myers Squibb, Gilead Sciences en... - Sep 10, 2006 Important Safety Information About ATRIPLA, Truvada, Viread and Emtriva Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Bristol-Myers Squibb and Gilead Sciences Establish Agreement to … - Sep 28, 2006 ATRIPLA, Truvada, Viread and Emtriva are not indicated for the treatment of chronic hepatitis B virus (HBV) infection and the safety and efficacy of these ... Genetic Engineering News - Genetic Engineering News (press release) Bloomberg Printer-Friendly Page - Dec 11, 2007 Emtriva, Viread, Truvada and ATRIPLA are not approved for the treatment of chronic ... In some of these patients treated with Emtriva, the exacerbations of ... Bloomberg Gilead, Royalty Pharma pay $525m for royalties. - Jul 25, 2005 A competitive bidding process drove up the price of the Emtriva royalties ... Gilead acquired Triangle in early 2003, and received approval of Emtriva later ... Free with registration - BioWorld Week - AccessMyLibrary.com … from Gilead's Study 934 Comparing Viread(R) and Emtriva(R) to... - Aug 18, 2006 Emtriva (emtricitabine) and Sustiva (efavirenz) to a twice-daily regimen of Combivir (lamivudine/zidovudine) with Sustiva once daily in treatment-naive ... Free with registration - M2 Presswire - AccessMyLibrary.com Netherlands Corporate News - Gilead Sciences meldt derde … - Oct 19, 2006 Emtriva Emtriva(R) (emtricitabine) sales were $9.3 million for the third quarter ... Emtriva sales volume has decreased due primarily to patients switching ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Gilead Buying Rest Of Corus; $365M Plus Lawsuit Payout - Jul 21, 2006 Emtriva sales, at $8.7 million, dipped 29 percent - again, mainly because of patients switching from an Emtriva-containing regimen to one containing Truvada ... BioWorld Online - BioWorld Online Analysis: AIDS cocktail down to 1 pill? - Apr 27, 2006 The pill contains emtricitabine (Emtriva) and tenofovir (Viread), developed by Gilead Sciences, and efavirenz (Sustiva), developed by Bristol-Myers Squibb. ... Free with registration - UPI Health Business - AccessMyLibrary.com … , a once-a-day tablet containing Gilead Sciences' anti-HIV drugs... - Feb 23, 2005 Truvada combines the company's anti-HIV medications Emtriva ... Emtriva was discovered and licensed to Gilead Sciences by Emory University in 1996. ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Gilead Is Nothing to Sneeze At - Oct 19, 2005 Truvada, which combines Gilead's existing drugs Viread and Emtriva, has been steadily gaining market share since it was approved by the Food and Drug ... Smartmoney.com US FDA Grants Traditional Approval for Gilead's Once-Daily HIV … - Mar 8, 2006 Eighty-four percent of patients in the Viread/Emtriva group compared to 73 percent of ... Truvada, Viread and Emtriva are not indicated for the treatment of ... RedOrbit Netherlands Corporate News - Amerikaanse FDA geeft toestemming aan … - Aug 3, 2006 Eighty-four percent of patients in the Viread/Emtriva group compared to 73 percent ... Important Safety Information for Truvada, Viread and Emtriva Lactic ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Gilead and Japan Tobacco Sign Licensing Agreement for Novel HIV … - Mar 22, 2005 Truvada, Viread and Emtriva are registered trademarks of Gilead Sciences, Inc. For more information on Gilead Sciences, please visit the company's web site ... Free with registration - Business Wire - AccessMyLibrary.com Event Brief of Q2 2005 Gilead Sciences Earnings Conference Call -... - Jul 19, 2005 This is an increase of 54% driven by increases in sales volumes for Viread and Emtriva, as well as the launch of Truvada in certain European countries in ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com abc13.com: Health news from KTRK about you and your family 7/31/06 - Jul 31, 2006 Atripla combines Viread (tenofovir), Emtriva (emtricitabine) and Sustiva (efavirenz). Viread and Emtriva, both made by Gilead of Foster City, Calif., ... go.com Emtriva has oral solution. - May 12, 2005 Emtriva has oral solution. Gilead Sciences has announced it is launching Emtriva 10mg/ml oral solution (emtricitabine) an antiretroviral product for ... $9.94 - Community Pharmacy - Alacra Store 144-Week Data From Gilead's Study 934 Comparing Truvada(R) to … - Jul 23, 2007 At study initiation, patients received Viread and Emtriva with Sustiva. At week 96, which coincided with commercial availability of Truvada in the United ... RedOrbit OVER THE COUNTER: New prescription product - Emtriva oral solution. - Jun 4, 2005 OVER THE COUNTER: New prescription product - Emtriva oral solution. Liquid containing emtricitabine 10mg/ml For use in HIV-1 infections or in combination ... $9.94 - Chemist & Druggist - Alacra Store … THE COUNTER: New prescription product - Emtriva oral solution.(Brie... - Jun 4, 2005 Liquid containing emtricitabine 10mg/ml Usual dose: 240mg (24ml) once daily in adults and 6mg/kg (up to 240mg) in children up to 18 years Gilead Sciences ... $4.95 - Chemist & Druggist - ECNext Oakland Tribune, The : Business<br> - Feb 25, 2005 Truvada combines the company's anti-HIV medications Emtriva and Viread in one tablet, taken once a day in combination with other antiretroviral agents. ... $2.95 - Oakland Tribune - NewsBank Gilead licenses HIV integrase inhibitor.(Wednesday, March 23)(Gilead ... - Mar 28, 2005 ...rights for Truvada (emtricitabine and tenofovir fumarate), Viread (tenofovir disoproxil fumarate) and Emtriva (emtricitabine) in Japan. Free with registration - BioWorld Week - AccessMyLibrary.com Truvada (tenofovir + emtricitabine) - Mar 1, 2008 Viread y Emtriva, ambos componentes de Truvada, son activos contra el ... de Viread y Emtriva para obtener mayor información sobre la posible resistencia. ... AIDSmeds.com HIV/AIDS Treatment News AIDS Cocktail Could Be Soon Down To Just One Pill - Apr 28, 2006 The pill contains emtricitabine (Emtriva) and tenofovir (Viread), developed by Gilead Sciences, and efavirenz (Sustiva), developed by Bristol-Myers Squibb. ... Space Daily A single daily pill for HIV - Aug 7, 2006 The new pill, named Atripla, combines efavirenz (Sustiva), emtricitabine (Emtriva), and tenofovir (Viread). It is a milestone in AIDS treatment. ... Cortlandt Forum Once-a-day HIV pill.(CLINICAL CAPSULES)(Brief Article) - Feb 1, 2005 Squibb's drug Sustiva (efavirenz), and Gilead's drug Truvada, which combines Emtriva (emtricitabine) and Viread (tenofovir disoproxil fumarate). ... Free with registration - Internal Medicine News - AccessMyLibrary.com Truvada get EU market approval.(Brief Article) - Mar 7, 2005 ...which is a fixed-dose once-a-day combined formulation of its anti-HIV drugs Viread (tenofovir disoproxil fumarate) and Emtriva (emtricitabine). ... Free with registration - Pharma Marketletter - AccessMyLibrary.com FDA approves single HIV antiretroviral pill.(NATION IN BRIEF)(Food... - Sep 1, 2006 Atripla, the first one-pill product to treat HIV/AIDS, combines the active ingredients of Sustiva, Emtriva and Viread. Bristol-Myers Squibb and Gilead ... Free with registration - Nation's Health - AccessMyLibrary.com DataBank: JULY 10-14; As Oil Soars, Stocks Give Up Gains for the Year - Jul 16, 2006 The components include Bristol-Myers Squibb's Sustiva and Gilead's Emtriva and Viread. The maker of pleasure boats, fitness equipment and bowling and ... nytimes.com Once-daily Kaletra approved for treatment-naive patients in USA ( … - May 4, 2005 In both these studies Kaletra was combined with tenofovir (Viread) and FTC (emtricitabine, Emtriva). In both arms of the study individuals took tenofovir ... Aidsmap OVER THE COUNTER: New prescription product - Emtriva oral solution - Jun 4, 2005 Liquid containing emtricitabine 10mg/ml For use in HIV-1 infections or in combination with other anti- retrovirals. Usual dose: 240mg (24ml) once daily in ... Pay-Per-View - Chemist & Druggist - Factiva, from Dow Jones Korosho approves JT's HIV treatments Emtriva, Truvada. - Apr 4, 2005 Two new treatments for HIV infection have been approved by Korosho. Japan Tobacco has developed both treatments one of which is in capsule form and the ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Gilead Provides Update on Development of Fixed-Dose Regimen of … - Aug 9, 2005 Safety and efficacy studies using Truvada tablets or using Emtriva and ... Emtriva and Viread have each been studied as part of multi-drug regimens and have ... $4.95 - Business Wire - ECNext First of a kind in HIV treatment. - Nov 1, 2006 The FDA approved Sustiva in 1998, Viread in 2001, and Emtriva in 2003. In addition, the safety and effectiveness of the combination of these three drugs ... $4.95 - FDA Consumer - ECNext … treatment combination)(Sustiva)(Truvada)(Emtriva)(Viread)(Brief... - Apr 1, 2005 ...a combination pill containing the nucleoside reverse transcriptase inhibitor ("nuke") Emtriva and the nucleotide reverse transcriptase inhibitor Viread. ... $4.95 - HIV Treatment: ALERTS! - ECNext Business Update; Gilead to develop, commercialize JTK-303 anti-HIV … - Apr 18, 2005 Viread (tenofovir disoproxil fumarate), Emtriva (emtricitabine) and Truvada (emtricitabine and tenofovir disoproxil fumarate) in Japan. ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones Gilead's 3rd-qtr sales rise 50% to record high.(Gilead Sciences... - Oct 24, 2005 However, turnover from Viread (tenofovir disoproxil) fell 2% to $189.4 million, while Emtriva (emtricitabine) revenues declined 26% to $11.7 million. ... $4.95 - Pharma Marketletter - ECNext emtricitabine Japan Tobacco marketed, Japan (HIV infection) Japan … - Apr 25, 2005 On 8 April 2005 Japan Tobacco announced that it plans to launch emtricitabine (EMTRIVA), an oral nucleoside reverse transcriptase inhibitor, in Japan on 19 ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Combivir (zidovudine + lamivudine) - Mar 1, 2008 Combivir no se debe tomar en combinación con Emtriva o Truvada (contiene Viread ... Ésto se debe a que Epivir de Combivir es muy similar a Emtriva y se cree ... AIDSmeds.com HIV/AIDS Treatment News Hunting AIDS: In Hot Pursuit, From the Day AIDS Was Discovered - Nov 30, 2007 The drug, called Emtriva, has led to the development of a new medicine that ... The AIDS drug that was developed using Emtriva is now taken by more than ... Emory Wheel - The Emory Wheel Gilead swings to 4th-quarter profit - Jan 23, 2008 Atripla is a combination of Gilead's Viread and Emtriva and Bristol-Myers Squibb Co.'s Sustiva. Meanwhile, sales of the HIV treatment Viread fell 7 percent ... Boston Globe 艾滋病控制新è?¯å°†ä¸Šå¸‚æ¯?æ—¥å?ªéœ€æœ?用1片 - Jul 12, 2006 ...å?³å°†æŽ¨å‡ºçš„æ¯?æ—¥1片的新è?¯ç”±ç™¾æ—¶ç¾Ž-施贵å®?å…¬å?¸ç”Ÿäº§çš„è?¯ç‰©Sustivaå’Œå?‰é‡Œå¾·ç§‘å¦å…¬å?¸ç”Ÿäº§ çš„è?¯ç‰©Truvada组å?ˆè€Œæˆ?，而Truvada本身包å?«è¯¥å…¬å?¸çš„å?¦å¤–两ç§?è?¯ç‰©ï¼šVireadå’ŒEmtriva ... 人民网 EE.UU. aprueba una nueva medicina diaria contra el sida - Jul 13, 2006 ..."Atripla", fabricada por la firma farmacéutica Bristol-Myers Squibb, contiene los medicamentos "Sustiva", "Viread" y "Emtriva" y es el último paso en los ... La Vanguardia 三å?ˆä¸€æ„›æ»‹ç—…新藥一天一粒æœ?用方便 - Jul 13, 2006 Vireadå’ŒEmtrivaå?‡ç”±åŠ å·žçš„å?‰è?Šå¾·ç§‘å¸å…¬å?¸(Gilead Sciences Inc)è£½é€ ï¼ŒSustiva則由 總部è¨åœ¨ç´?約的「必治妥施貴寶ã€?å…¬å?¸è£½é€ 。 Atripla能å?–代兩種以上HIV病毒陽性患者 ... è?¯å?ˆæ–°è?žç¶² Netherlands Corporate News - Bristol-Myers Squibb en Gilead Sciences ... - Nov 12, 2007 Emtriva, Viread, Truvada and ATRIPLA are not approved for the treatment of chronic ... In some of these patients treated with Emtriva, the exacerbations of ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Development of NRTI Reverset Halted - Apr 4, 2006 Approximately 70% of patients in Study 901 were on regimens containing either Epivir or Emtriva. After the results of Study 203 demonstrated that the ... AIDSmeds.com HIV/AIDS Treatment News EUA aprovam droga contra a Aids de dose diária - Jul 12, 2006 O Viread eo Emtriva já aparecem em um único comprimido, o Truvada, que foi lançado no ano passado e deve vender 1 bilhão de dólares em 2006. ... Terra Brasil Brand Names/Synonyms: Emtriva is also known by the following brand names and/or synonyms524W91; BW 1592; BW 524W91; Coviracil; DRG-0208; Dotfc; Emtricitabine; Emtriva; FTC; Racivir; Truvada Drug Category: Emtriva is categorized under the following by the FDA: Anti-HIV Agents; ATC:J05AF09 Dosage Forms: TABLETS Absorption: Rapidly absorbed (93%) Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-pyrimidin-2-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |